癌診療指針のための病理診断プラクティス　婦人科腫瘍

出版社： 中山書店
著者：
発行日： 2015-12-25
分野： 臨床医学：一般  >  癌/腫瘍一般
ISBN： 9784521742687
シリーズ： 癌診療指針のための病理診断プラクティス
電子書籍版： 2015-12-25 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

22,000 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

22,000 円(税込)

購入する

商品紹介

婦人科の病理検体は消化管検体に次ぐ数を占める施設が多いにもかかわらず，腫瘍の種類が多いうえに，分野独特の考え方や命名法があるため，必要以上に難しく感じられる．本書では異名のある疾患名は併記したり，現場での慣行を踏まえた用語を使用し，この分野の初学者にもわかりやすい編集を意識している．癌診療に携わる病理医はもちろん外科医など関係するすべての医療関係者に必携の書！

目次

  • 癌診療指針のための病理診断プラクティス　婦人科腫瘍

    ―目次―

    1章　病理診断の流れとポイント
    2章　診断のための基本知識
    3章　子宮腫瘍の概要と鑑別診断
    4章　卵巣腫瘍の概要と鑑別診断
    5章　卵管・広間膜腫瘍の概要と鑑別診断
    6章　腟・外陰腫瘍の概要と鑑別診断
    7章　病理検体の取り扱い
    8章　症例の実際

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 病理診断の流れとポイント

P.2 掲載の参考文献
Karen H Lu編. 青木大輔監訳. 遺伝性婦人科癌-リスク・予防・マネジメント. 東京 : 医学書院 ; 2011.
 
新井正美編. 癌の遺伝医療. 東京 : 南江堂 ; 2015.
 
縄田修吾ほか. 子宮頸癌の検診・診断. 腫瘍マーカー, バイオマーカー. 日本臨牀 2012 ; 70 : S167-70.
 
馬場長ほか. 子宮体癌の検診・診断. 腫瘍マーカー, バイオマーカー. 日本臨牀 2012 ; 70 : S372-6.
 
片岡史夫, 青木大輔. 卵巣癌の検診・診断. 腫瘍マーカー, バイオマーカー. 日本臨牀 2012 ; 70 : S543-8.
 
本山悌一. ベセスダシステムの精神と細胞診・組織診の精度管理. 日臨細胞誌 2012 ; 51 ; 39-41.
Medical*Online
本山悌一. 子宮頸部生検において正確な病理診断を得るために. 日婦病理会誌 2012 ; 3 ; 39-46.
 

2章 診断のための基本知識

P.10 掲載の参考文献
Andreano A, et al. MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer : a systematic review and meta-analysis. Eur Radiol 2014 ; 24 : 1327-38.
PubMed
Chang MC, et al. 18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer : a systematic review and meta-analysis. Eur J Radiol 2012 ; 81 : 3511-7.
 
Kobayashi H, et al. Risk of developing ovarian cancer among women with ovarian endometrioma : a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 2007 ; 17 : 37-43.
PubMed
Kurman RJ, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer : a proposed unifying theory. Am J Surg Pathol 2010 ; 34 : 433-43.
PubMed
Perez-Medina T, et al. Prospective evaluation of 18-fluoro-2-deoxy-D-glucose positron emission tomography for the discrimination of paraaortic nodal spread in patients with locally advanced cervical carcinoma. Int J Gynecol Cancer 2013 ; 23 : 170-5.
PubMed
Yoshizako T, et al. MR imaging of uterine adenosarcoma : case report and literature review. Magn Reson Med Sci 2011 ; 10 : 251-4.
PubMed
今岡いずみ, 田中優美子. 婦人科MRIアトラス. 東京 : 学研メディカル秀潤社 ; 2004.
 
田中優美子. 産婦人科の画像診断. 東京 : 金原出版 ; 2014.
 
P.19 掲載の参考文献
平成20 年度 厚生労働省がん研究助成金「がん検診の適切な方法とその評価法の確立に関する研究」班, 平成21年度 厚生労働省がん研究助成金「がん検診の評価とあり方に関する研究」班 (主任研究者 : 濱島ちさと). 有効性評価に基づく子宮頸がん検診ガイドライン. 2009. http://canscreen.ncc.go.jp/pdf/guideline/shikyukei-full0912.pdf
 
Solomon D, Nayar R編, 平井康夫監訳. ベセスダシステム 2001 アトラス. 東京 : シュプリンガー・ジャパン ; 2007.
 
日本産科婦人科学会ほか編. 子宮頸癌取扱い規約. 第3版. 東京 : 金原出版 ; 2012. p.13-4.
 
日本産婦人科医会. ベセスダシステム 2001 準拠子宮頸部細胞診報告様式の理解のために. 2008.
 
日本産科婦人科学会, 日本産婦人科医会編. 産婦人科診療ガイドライン-婦人科外来編 2014. 2014.
 
Saslow D, et al. American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012 ; 62 : 147-72/Am J Clin Pathol 2012 ; 137 : 516-42.
 
Kino M, et al. Endometrial lesion cytodiagnosis comparing the Masubuchi method and Honest Super Brush. 日臨細胞誌 2012 ; 51 : 105-9.
 
Hasumi K, et al. Small endometrial carcinoma 10 mm or less in diameter : clinicopathologic and histogenetic study of 131 cases for early detection and treatment. Cancer Med 2013 ; 2 : 872-80.
 
日本産科婦人科学会ほか編. 子宮体癌取扱い規約. 第3版. 東京 : 金原出版 ; 2012. p.15.
 
杉山裕子ほか. 細胞診と組織診からみた子宮体癌の診断. 日臨細胞誌 2008 ; 47 : 324-9.
 
Yanoh K, et al. New diagnostic reporting format for endometrial cytology based on cytoarchitectural criteria. Cytopathology 2009 ; 20 : 388-94.
PubMed
Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009 ; 105 : 103-4.
PubMed
日本婦人科腫瘍学会編. 子宮体がん治療ガイドライン 2013年版. 東京 : 金原出版 ; 2013.
 
日本婦人科腫瘍学会編. 子宮頸癌治療ガイドライン 2011年版. 東京 : 金原出版 ; 2011.
 
日本臨床細胞学会編. 細胞診ガイドライン 1 婦人科・泌尿器 2015年版. 東京 : 金原出版 ; 2015.
 
日本産科婦人科学会, 日本病理学会編. 卵巣腫瘍・卵管癌・腹膜癌取扱い規約 臨床編. 第1版. 東京 : 金原出版 ; 2015.
 
P.28 掲載の参考文献
Yasuda M, et al. Endometrial intraepithelial carcinoma in association with polyp : review of eight cases. Diagn Pathol 2013 ; 8 : 25.
PubMed
Zheng W, et al. A proposed model for endometrial serous carcinogenesis. Am J Surg Pathol 2011 ; 35 : E1-14.
 
Yemelyanova A, et al. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas : utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Am J Surg Pathol 2009 ; 33 : 914-24.
PubMed
Chivukula M, et al. Carcinomas of Distal Fallopian Tube and Their Association with Tubal Intraepithelial Carcinoma : Do They Share a Common "Precursor" Lesion? Loss of Heterozygosity and Immunohistochemical Analysis Using PAX 2, WT-1, and P53 Markers. ISRN Obstet Gynecol 2011 ; 2011 : 858647.
 
Jones S, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010 ; 8 : 228-31.
 
Wiegand KC, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010 ; 14 : 1532-43.
 
Cao D, et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 2009 ; 33 : 894-904.
PubMed
Maeda D, et al. Glypican-3 expression in clear cell adenocarcinoma of the ovary. Mod Pathol 2009 ; 22 : 824-32.
PubMed
Cheng L, et al. OCT4 : biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 2007 ; 211 : 1-9.
PubMed
Katoh T, et al. Estrogen-producing endometrioid adenocarcinoma resembling sex cordstromal tumor of the ovary : a review of four postmenopausal cases. Diagn Pathol 2012 ; 7 : 164.
PubMed
Miettinen M, et al. SALL4 expression in germ cell and non-germ cell tumors : a systematic immunohistochemical study of 3215 cases. Am J Surg Pathol 2014 ; 38 : 410-20.
PubMed
P.36 掲載の参考文献
日本産科婦人科学会ほか編. 子宮頸癌取扱い規約. 第3版. 東京 : 金原出版 ; 2012.
 
日本婦人科腫瘍学会編. 子宮頸癌治療ガイドライン 2011年版. 東京 : 金原出版 ; 2011.
 
Sevin BU, et al. Microinvasive carcinoma of the cervix. Cancer 1992 ; 70 : 2121-8.
PubMed
van Meurs H, et al. Frequency of pelvic lymph node metastases and parametrial involvement in stage IA2 cervical cancer : a population-based study and literature review. Int J Gynecol Cancer 2009 ; 19 : 21-6.
 
Elliott P, et al. Early invasive (FIGO stage IA) carcinoma of the cervix : a clinicopathologic study of 476 cases. Int J Gynecol Cancer 2000 ; 10 : 42-52.
PubMed
日本産科婦人科学会婦人科腫瘍委員会報告. 2012年度患者年報. 2014年3月. http://plaza.umin.ac.jp/~jsog-go/kanja_2012.pdf
 
National Comprehensive Cancer Network. NCCN Guidelines(R). http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
 
Fuller AF Jr, et al. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol 1989 ; 33 : 34-9.
PubMed
Micha JP, et al. Surgery alone or surgery with a combination radiation or chemoradiation for management of patients with bulky-stage IB2 cervical carcinoma. Int J Gynecol Cancer 2006 ; 16 : 1147-51.
 
Niikura H, et al. Sentinel lymph node detection in early cervical cancer with combination 99mTc phytate and patent blue. Gynecol Oncol 2004 ; 94 : 528-32.
PubMed
Kim SM, et al. Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer 2000 ; 10 : 305-12.
PubMed
Olawaiye A, et al. Abdominal radical trachelectomy : Success and pitfalls in a general gynecologic oncology practice. Gynecol Oncol 2009 ; 112 : 506-10.
 
Diaz JP, et al. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. Gynecol Oncol 2008 ; 111 : 255-60.
PubMed
P.43 掲載の参考文献
Matsuda T, et al. The Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2002 : based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2008 ; 38 : 641-8.
 
片渕秀隆, 田代浩徳. 内膜癌の分子生物学. 石倉浩ほか編. 子宮腫瘍病理アトラス. 東京 : 文光堂 ; 2007. p.62-9.
 
Gunter MJ, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev 2008 ; 17 : 921-9.
PubMed
Levin VV, et al. Biological sigficance of prolactin in gynecologic cancers. Cancer Res 2009 ; 69 : 5226-33.
 
日本産科婦人科学会ほか編. 子宮体癌取扱い規約. 第3版. 東京 : 金原出版 ; 2012.
 
日本婦人科腫瘍学会編. 子宮体がん治療ガイドライン 2013年版. 東京 : 金原出版 ; 2013.
 
Johnson N, et al. Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database Syst Rev 2011 ; 10 : CD003175.
PubMed
Lewin SN, et al. Comparative performance of the 2009 international Federation of gynecology and obstetrics, staging system for uterine corpus cancer. Obstet Gynecol 2010 ; 116 : 1141-9.
PubMed
Evans-Metcalf ER, et al. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 1998 ; 91 : 349-54.
PubMed
Thigpen JT, et al. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma : a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 1999 ; 17 : 1736-44.
PubMed
齋藤文誉ほか. 若年発症子宮内膜癌の病態におけるプロラクチンの臨床的意義. 日婦腫瘍会誌 2011 ; 29 : 697-703.
 
P.52 掲載の参考文献
WHO GLOBOCAN 2012 Population Fact Sheets, http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
 
国立がん研究センターがん対策情報センター データベース http://gdb.ganjoho.jp/graph_db/index?lang=ja
 
日本産科婦人科学会, 日本病理学会編. 卵巣腫瘍取扱い規約 第1部 組織分類ならびにカラーアトラス. 第2版. 東京 : 金原出版 ; 2009. p.42.
 
Ferraro S, et al. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis : a systematic review. J Clin Pathol 2013 ; 66 : 273-81.
PubMed
Prat J, FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 2014 ; 124 : 1-5.
PubMed
Kurman RJ, Shih leM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer- shifting the paradigm. Hum Pathol 2011 ; 42 : 918-31.
 
日本婦人科腫瘍学会編. 卵巣がん治療ガイドライン 2015年版. 東京 : 金原出版 ; 2015.
 
日本産科婦人科学会編. 卵巣腫瘍取扱い規約 第2部. 第2版. 東京 : 金原出版 ; 1997. p.9-14.
 
日本産科婦人科学会婦人科腫瘍委員会. 婦人科腫瘍委員会報告 2012年度患者年報. 日産婦誌 2014 ; 66 : 995-1038.
 
日本産科婦人科学会, 日本病理学会編. 卵巣腫瘍・卵管癌・腹膜癌取扱い規約 臨床編. 第1版. 東京 : 金原出版 ; 2015.
 

3章 子宮腫瘍の概要と鑑別診断

P.64 掲載の参考文献
Darragh TM, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions : background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med 2012 ; 136 : 1266-97.
PubMed
Quinn MA, et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006 ; 95 : S43-103.
PubMed
Koenig C, et al. Papillary squamotransitional cell carcinoma of the cervix : a report of 32 cases. Am J Surg Pathol 1997 ; 21 : 915-21.
PubMed
Chao A, et al. Does Epstein-Barr virus play a role in lymphoepithelioma-like carcinoma of the uterine cervix? Int J Gynecol Pathol 2009 ; 28 : 279-85.
PubMed
Moscicki AB, et al. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine 2012 ; 30 : F24-33.
PubMed
P.81 掲載の参考文献
Ioffe OB, et al. Proposal of a new scoring sheme for the diagnosis of noninvasive endocervical glandular lesions. Am J Surg Pathol 2003 ; 27 : 452-60.
 
Lee KR, Flynn CE. Early invasive adenocarcinoma of the cervix. A histopathologic analysis of 40 cases with observations concerning histogenesis. Cancer 2000 ; 89 : 1048-55.
 
Young RH, Clement PB. Endocervical adenocarcinoma and its variants : their morphology and differential diagnosis. Histopathology 2002 ; 41 : 185-207.
PubMed
Mikami Y, McCluggage WG. Endocervical glandular lesions exhibiting gastric differentiation : an emerging spectrum of benign, premalignant, and malignant lesions. Adv Anat Pathol 2013 ; 20 : 227-37.
PubMed
P.105 掲載の参考文献
Kurman RJ, et al. eds. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon : IARC ; 2014.
 
日本産科婦人科学会ほか編. 子宮頸癌取扱い規約. 第3版. 東京 : 金原出版 ; 2012.
 
加藤哲子. 腺扁平上皮癌. 腫瘍病理鑑別診断アトラス 子宮頸癌. 東京 : 文光堂 ; 2009. p.100-6.
 
加藤哲子. 腺扁平上皮癌. 子宮腫瘍病理アトラス. 東京 : 文光堂 ; 2007. p.165-6.
 
九島巳樹, 本山悌一. 腺様嚢胞癌. 子宮腫瘍病理アトラス. 東京 : 文光堂 ; 2007. p.167-9.
 
石倉浩. 腺様基底細胞癌. 子宮腫瘍病理アトラス. 東京 : 文光堂 ; 2007. p.170-1.
 
P.112 掲載の参考文献
Kurman RJ, et al. eds. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon : IARC ; 2014.
 
日本産科婦人科学会ほか編. 子宮頸癌取扱い規約. 第3版. 東京 : 金原出版 ; 2012.
 
本山悌一. 神経内分泌腫瘍. 腫瘍病理鑑別診断アトラス 子宮頸癌. 東京 : 文光堂 ; 2009. p.107-12.
 
清川貴子. 神経内分泌腫瘍. 子宮腫瘍アトラス. 東京 : 文光堂 ; 2007, p.172-5.
 
大場岳彦, 石川雄一. 肺神経内分泌腫瘍の分類と組織診断. 病理と臨 28 : 151-5.
Medical*Online
長村義之. 神経内分泌腫瘍の分類とその問題. 病理と臨 29 : 440-3.
Medical*Online
元井紀子, 石川雄一. 肺に発生する神経内分泌腫瘍. 病理と臨 29 : 444-50.
Medical*Online
大池信之, 諸星利男. 膵・消化管に発生する神経内分泌腫瘍. 病理と臨 29 : 451-9.
Medical*Online
P.118 掲載の参考文献
Kurman RJ, et al. eds. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon : IARC ; 2014.
 
日本産婦人科学会ほか編. 子宮体癌取扱い規約. 第3版. 東京 : 金原出版 ; 2012.
 
日本産婦人科学会ほか編. 子宮頸癌取扱い規約. 第3版. 東京 : 金原出版 ; 2012.
 
Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus : a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2002 ; 9 : 145-84.
PubMed
Clement PB, Young RH. Non-endometrioid carcinomas of the uterine corpus : a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2004 ; 11 : 117-42.
PubMed
Hamilton CA, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer 2006 ; 94 : 642-6.
PubMed
Silva EG, et al. Undifferentiated carcinoma of the endometrium : a review. Pathology 2007 ; 39 : 134-8.
PubMed
Ip PP, et al. Papillary proliferation of the endometrium : a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia. Am J Surg Pathol 2013 ; 37 : 167-77.
PubMed
P.135 掲載の参考文献
McCluggage WG, et al. Uterine endometrial stromal sarcoma with smooth muscle and glandular differentiation. J Clin Pathol 2001 ; 54 : 481-3.
PubMed
Baker PM, et al. Unusual morphologic features of endometrial stromal tumors : a report of 2 cases. Am J Surg Pathol 2005 ; 29 : 1394-8.
PubMed
Chiang S, Oliva E. Recent developments in uterine mesenchymal neoplasms. Histopathology 2013 ; 62 : 124-37.
PubMed
Oliva E. Cellular mesenchymal tumors of the uterus : a review emphasizing recent observations. Int J Gynecol Pathol 2014 ; 33 : 374-84.
PubMed
Sciallis AP, et al. High-grade endometrial stromal sarcomas : a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features. Am J Surg Pathol 2014 ; 38 : 1161-72.
PubMed
P.144 掲載の参考文献
Bell SW, et al. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994 ; 18 : 535-58.
PubMed
Ip PP, et al. Uterine smooth muscle tumors of uncertain malignant potential (STUMP) : A clinicopathologic analysis of 16 cases. Am J Surg Pathol 2009 ; 33 : 992-1005.
 
Chiang S, Oliva E. Recent developments in uterine mesenchymal neoplasms. Histopathology 2013 ; 62 : 124-37.
PubMed
Crose S, et al. Uterine leiomyomas with bizarre nuclei. A clinicopathologic study of 59 cases. Am J Surg Pathol 2014 ; 38 : 1330-9.
 
本山悌一. 子宮体部平滑筋腫瘍. 病理と臨 2008 ; 26 : 374-9.
Medical*Online
清川貴子. 子宮平滑筋肉腫の病理像. 日婦腫瘍会誌 2015 ; 33 : 153-60.
 
P.156 掲載の参考文献
Clement PB, Scully RE. Mullerian adenosarcoma of the uterus : a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 1990 ; 21 : 363-81.
PubMed
Mourits MJ, et al. Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 2001 ; 97 : 855-66.
PubMed
Wada H, et al. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res 1997 ; 57 : 5379-85.
 
田中優美子. 子宮体部の腫瘍とその前駆病変 非上皮性腫瘍と関連病変. 産婦人科の画像診断. 東京 : 金原出版 ; 2014. p.207-39.
 
Mazur MT. Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 1981 ; 5 : 473-82.
PubMed
Young RH, et al. Atypical polypoid adenomyoma of the uterus. A report of 27 cases. Am J Clin Pathol 1986 ; 86 : 139-45.
PubMed
Kurman RJ, et al. Blaustein's Pathology of the Female Genital Tract. New York : Springer ; 2011. p.426-30, p.500-6.
 
P.167 掲載の参考文献
Hui P, et al. Gestational trophoblastic disease. In : Kurman RJ, et al. eds. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon : IARC ; 2014. p.155-68.
 
日本産科婦人科学会, 日本病理学会編. 絨毛性疾患取扱い規約. 第3版. 東京 : 金原出版 ; 2011.
 
Szulman AE. Trophoblastic diseases : complete and partial moles. In : Lewis SH, Perrin E, eds. Pathology of the Placenta, 2nd ed. Churchill Livingstone ; 1999. p.259-81.
 
Fukunaga M, et al. Incidence of hydatidiform mole in a Tokyo hospital : a 5-year (1989-1993) prospective, morphological, and flow cytometric study. Hum Pathol 1995 ; 26 : 758-64.
 
Fukunaga M. Immunohistochemical characterization of p57 (KIP2) expression in early hydatidiform moles. Hum Pathol 2002 ; 33 : 1188-92.
PubMed
Fukunaga M, et al. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol 2005 ; 29 : 942-7.
PubMed
Baergen RN, et al. Placental site trophoblastic tumor : A study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 2006 ; 100 : 511-20.
PubMed
Shih IM, Kurman RJ. Epithelioid trophoblastic tumor : a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 1998 ; 22 : 1393-403.
PubMed
Fukunaga M, Ushigome S. Metastasizing placental site trophoblastic tumor. An immunohistochemical and flow cytometric study of two cases. Am J Surg Pathol 1993 ; 17 : 1003-10.
PubMed
Young RH, et al. Placental site nodules and plaques. A clinicopathologic analysis of 20 cases. Am J Surg Pathol 1990 ; 14 : 1001-9.
PubMed

4章 卵巣腫瘍の概要と鑑別診断

P.194 掲載の参考文献
Bell DA, et al. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors : workshop perspectives. Hum Pathol 2004 ; 35 : 934-48.
PubMed
Longacre TA, et al. Ovarian serous tumors of low malignant potential (borderline tumors) : outcome-based study of 276 patients with long-term (> or =5-year) follow-up. Am J Surg Pathol 2005 ; 29 : 707-23.
PubMed
Seidman JD, et al. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon : IARC ; 2014. p.17-24.
 
Seidman JD, Kurman RJ. Ovarian serous borderline tumors : a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000 ; 31 : 539-57.
PubMed
Prat J, De Nictolis M. Serous borderline tumors of the ovary : a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002 ; 26 : 1111-28.
PubMed
Bell DA, et al. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer 1988 ; 62 : 2212-22.
PubMed
Burks RT, et al. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996 ; 20 : 1319-30.
PubMed
Eichhorn JH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns : a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999 ; 23 : 397-409.
PubMed
Singer G, et al. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis : a mutational analysis with immunohistochemical correlation. Am J Surg Pathol 2005 ; 29 : 218-24.
PubMed
Kindelberger DW, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma : Evidence for a causal relationship. Am J Surg Pathol 2007 ; 31 : 161-9.
PubMed
P.207 掲載の参考文献
Riopel MA, et al. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors : atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol 1999 ; 23 : 617-35.
PubMed
Rodriguez IM, Prat J. Mucinous tumors of the ovary : a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol 2002 ; 26 : 139-52.
PubMed
Shappell HW, et al. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors : atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol 2002 ; 26 : 1529-41.
PubMed
P.230 掲載の参考文献
Roth LM, et al. Ovarian clear cell adenofibromatous tumors. Cancer 1984 ; 53 : 1156-63.
PubMed
Bell DA, Scully RE. Benign and borderline clear cell adenofibromas of the ovary. Cancer 1985 ; 56 : 2922-31.
PubMed
Clear cell tumors. In : Scully RE, et al, eds. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Atlas of Tumor Pathology. Washington D. C. : AFIP ; 1998. p.141-51.
 
Sugiyama T, et al. Clinical characteristics of clear cell carcinoma of the ovary. A distinct histologic type with poor prognosis and resistence to platinum-based chemotherapy. Cancer 2000 ; 88 : 2584-9.
PubMed
Jones S, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010 ; 330 : 228-31.
PubMed
Kurman RJ, Shih IM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer. Shifting the paradigm. Hum Pathol 2011 ; 42 : 918-31.
PubMed
Seidman JD, et al. Surface epithelial tumors of the ovary. In : Kurman RJ, et al. eds. Blaustein's Pathology of the Female Genital Tract. 6th ed. New York, Dodrecht, Heidelberg, London : Springer ; 2011. p.679-784.
 
Gilks CB, et al. Clear cell tumours. In : Kurman RJ, et al. eds. WHO Classification of Tumours of Female Reproductive Organs. Lyon : IARC ; 2014. p.33-5.
 
Tsuchiya A, et al. Expression profiling in ovarian clear cell carcinoma. Identification of hepatocyte nuclear factor-1β as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol 2003 ; 163 : 2503-12.
 
Kandalaft PL, et al. The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary. Am J Clin Pahol 2014 ; 142 : 830-6.
 
Ramalingam P, et al. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol 2004 ; 28 : 1499-505.
PubMed
Cao D, et al. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer 2009 ; 115 : 2640-51.
PubMed
P.238 掲載の参考文献
日本産科婦人科学会, 日本病理学会編. 卵巣腫瘍取扱い規約 第1部 組織分類ならびにカラーアトラス. 第2版. 東京 : 金原出版 ; 2009.
 
Tavassoli FA, Daviles P, eds. WHO Classification of tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs, 3rd ed. Lyon : IARC ; 2003.
 
Kurman RJ, et al. eds. WHO Classification of Tumours of Female Reproductive Organs, 4th ed. Lyon : IRAC ; 2014.
 
Takeuchi T, et al. Ovarian transitional cell carcinoma represents a poorly differentiated form of high-grade serous or endometrioid adenocarcinoma. Am J Surg Pathol 2013 ; 37 : 1091-9.
PubMed
Ali RH, et al. Transitinal cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant Brenner tumor. Int J Gynecol Pathol 2012 ; 31 : 499-506.
PubMed
Gezginc K, et al. Malignant Brenner tumor of the ovary : Analysis of 13 cases. Int J Clin Oncol 2012 ; 17 : 324-9.
PubMed
Amogiannaki N, et al. Proliferative Brenner tumor of the ovary. Clinicopathological study of two cases and review of literature. Eur J Gynaecol Oncol 2011 ; 32 : 576-8.
 
Kondi-Pafiti A, et al. Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors. Arch Gynecol Obstet 2012 ; 285 : 1699-702.
PubMed
P.245 掲載の参考文献
Jacobsen GK, Talerman A. Atlas of germ cell tumours. Copenhagen : Munksgaard ; 1989.
 
Cheng L, et al. KIT gene mutation and amplification in dysgerminoma of the ovary. Cancer 2011 ; 117 : 2096-103.
PubMed
Ulbright TM, et al. Yolk sac differentiation in germ cell tumors. A morphologic study of 50 cases with emphasis on hepatic, enteric, and parietal yolk sac features. Am J Surg Pathol 1986 ; 10 : 151-64.
PubMed
Cao D, et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 2009 ; 33 : 894-904.
PubMed
Nogales FF, et al. Germ cell tumors of the ovary : an update. Arch Pathol Lab Med 2014 ; 138 : 351-62.
PubMed
Merard R, et al. Growing Teratoma Syndrome : A Report of 2 Cases and Review of the Literature. Int J Gynecol Pathol 2015 ; 34 : 465-72.
PubMed
Motoyama T, et al. Functioning ovarian carcinoids induce severe constipation. Cancer 1992 ; 70 : 513-8.
PubMed
Sakuma M, et al. Malignant transformation arising from mature cystic teratoma of the ovary : a retrospective study of 20 cases. Int J Gynecol Cancer 2010 ; 20 : 766-71.
PubMed
P.265 掲載の参考文献
Shah SP, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 2009 ; 360 : 2719-29.
PubMed
Al-Agha OM, et al. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 2011 ; 35 : 484-94.
PubMed
Heravi-Moussavi A, et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 2012 ; 366 : 234-42.
PubMed
Cathro HP, Stoler MH. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Hum Pathol 2005 ; 36 : 195-201.
PubMed
Irving JA, Young RH. Microcystic stromal tumor of the ovary : report of 16 cases of a hitherto uncharacterized distinctive ovarian neoplasm. Am J Surg Pathol 2009 ; 33 : 367-75.
PubMed
Burandt E, Young RH. Thecoma of the ovary : a report of 70 cases emphasizing aspects of its histopathology different from those often portrayed and its differential diagnosis. Am J Surg Pathol 2014 ; 38 : 1023-32.
PubMed
Roth LM, et al. On the pathogenesis of sclerosing stromal tumor of the ovary : a neoplasm in transition. Int J Gynecol Pathol 2014 ; 33 : 449-62.
PubMed
Rabban JT, Zaloudek CJ. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Histopathology 2013 ; 62 : 71-88.
PubMed
本山悌一, 坂本穆彦編. 腫瘍病理鑑別診断アトラス 卵巣腫瘍. 東京 : 文光堂 ; 2012.
 
石倉浩, 手島伸一編. 卵巣腫瘍病理アトラス. 東京 : 文光堂 ; 2004.
 
Kurman RJ, et al. ed. Blaustein's Pathology of the Female Genital Tract. 6th ed. New York : Springer ; 2011.
 
Kurman RJ, et al. eds. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon : IARC ; 2014.
 
P.291 掲載の参考文献
Young RH, et al. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol 1994 ; 18 : 1102-16.
PubMed
Eichhorn JH, et al. Primary ovarian small cell carcinoma of pulmonary type. A clinicopathologic, immunohistologic, and flow cytometric analysis of 11 cases. Am J Surg Pathol 1992 ; 16 : 926-38.
PubMed
Veras E, et al. Ovarian nonsmall cell neuroendocrine carcinoma : a clinicopathologic and immunohistochemical study of 11 cases. Am J Surg Pathol 2007 ; 31 : 774-82.
PubMed
Clement PB, et al. Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas. Am J Surg Pathol 1996 ; 20 : 1067-80.
PubMed
Young RH, et al. Ovarian and juxtaovarian adenomatoid tumors : a report of six cases. Int J Gynecol Pathol 1991 ; 10 : 364-71.
PubMed
Axe SR, et al. Choriocarcinoma of the ovary. Obstet Gynecol 1985 ; 66 : 111-4.
PubMed
Lash RH, Hart WR. Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathologic evaluation of 22 cases. Am J Surg Pathol 1987 ; 11 : 114-21.
 
Young RH. From Krukenberg to today : the ever present problems posed by metastatic tumors in the ovary. Part II. Adv Anat Pathol 2007 ; 14 : 149-77.
PubMed
Meriden Z, et al. Ovarian metastases of pancreaticobiliary tract adenocarcinomas : analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors. Am J Surg Pathol 2011 ; 35 : 276-88.
PubMed
Karanian-Philippe M, et al. SMARCA4 (BRG1) Loss of Expression Is a Useful Market for the Diagnosis of Ovarian Small Cell Carcinoma of the Hypercalcemic Type (Ovarian Rhabdoid Tumor) : A Comprehensive Analysis of 116 Rare Gynecologic Tumors, 9 Soft Tissue Tumors, and 9 Melanomas. Am J Surg Pathol 2015 ; 39 : 1197-205.
 

5章 卵管・広間膜腫瘍の概要と鑑別診断

P.308 掲載の参考文献
Crum CP, et al. Tumour of the fallopian tube. In : Kurman RJ, et al. eds. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon : IARC ; 2014. p.103-12.
 
Lawrence WD, et al. Tumour of the broad ligament and other uterine ligaments. In : Kurman RJ, eds. WHO Classification of Tumours of Female Reproductive Organs. Lyon : IARC ; 2014. p.113-20.
 
Vang R, Wheeler JE. Disease of the fallopian tube and paratubal region. In : Kurman RJ, eds. Blaustein's Pathology of the Female Genital Tract, 6th ed. New York : Springer ; 2011. p.529-78.
 
Chang PS, Crum CP. The fallopian tube and broad ligament. In : Crum CP, eds. Diagnostic Gynecologic and Obstetric Pathology. Philadelphia : Elsevier Saunders ; 2006. p.675-712.
 
Devouassoux-Shisheboran M, et al. Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO). Immunohistochemical evidence in support of a Wolffian origin. Hum Pathol 1999 : 30 ; 856-63.
PubMed
Baker PM, et al. Malignant peritoneal mesothelioma in woman : a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. Am J Clin Pathol 2005 : 123 ; 724-37.
PubMed

6章 腟・外陰腫瘍の概要と鑑別診断

P.318 掲載の参考文献
Kurman RJ, et al, eds. Blaustein's Pathology of the Female Genital Tract. 6th ed. New York : Springer ; 2011.
 
Kurman RJ, et al. eds. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon : IARC ; 2014.
 
De Vuyst H, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus : a meta-analysis. Int J Cancer 2009 ; 124 : 1626-36.
 
FIGO Committee on Gynecologic Oncology. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet 2009 ; 105 : 3-4.
PubMed
Tavassoli FA, Norris HJ. Smooth muscle tumors of the vagina. Obstet Gynecol 1979 ; 53 : 689-93.
PubMed
Magro G. Stromal tumors of the lower female genital tract : histogenetic, morphological and immunohistochemical similarities with the "benign spindle cell tumors of the mammary stroma". Pathol Res Pract 2007 ; 203 : 827-9.
PubMed
Oda Y, Tsuneyoshi M. Extrarenal rhabdoid tumors of soft tissue : clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features. Pathol Int 2006 ; 56 : 287-95.
PubMed

7章 病理検体の取り扱い

P.332 掲載の参考文献
日本産科婦人科学会ほか編. 子宮頸癌取扱い規約. 第3版. 東京 : 金原出版 ; 2012.
 
日本産科婦人科学会ほか編. 子宮体癌取扱い規約. 第3版. 東京 : 金原出版 ; 2012.
 
P.341 掲載の参考文献
日本皮膚悪性腫瘍学会編. 皮膚悪性腫瘍取扱い規約. 第2版. 東京 : 金原出版 ; 2010.
 
Lester S C. Gynecologic and Perinatal pathology. In : Manual of surgical pathology 3rd ed. Philadelphia : Elsevier Saunders ; 2010. p.423-72.
 
Rosai K, Appendix E. Guidelines for handling of most common and important surgical specimens. In : Rosai and Ackerman's Surgical Pathology. 10th ed. Elsevier Mosby : 2011. p.2581-636.
 

8章 症例の実際

P.348 掲載の参考文献
Moutte A, et al. Placental site and epithelioid trophoblastic tumours : diagnostic pitfalls. Gynecol Oncol 2013 ; 128 : 568-72.
PubMed
Shih IM, Kurman RJ. Epithelioid trophoblastic tumor : a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 1998 ; 22 : 1393-403.
PubMed
Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 2001 ; 20 : 31-47.
PubMed
Kalhor N, et al. Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol 2009 ; 33 : 633-8.
PubMed
Fadare O, et al. Epithelioid trophoblastic tumor : clinicopathological features with an emphasis on uterine cervical involvement. Mod Pathol 2006 ; 19 : 75-82.
 
P.354 掲載の参考文献
Huntsman DG, et al. Small-cell carcinoma of the endometrium. A Clinicopathological study of sixteen cases. Am J Surg Pathol 1994 ; 18 : 364-75.
PubMed
Sato H, et al. Small-cell carcinoma of the endometrium presenting as Cushing's syndrome. Endocr J 2010 ; 57 : 31-8.
PubMed
Lojek MA, et al. Cushing's syndrome with small cell carcinoma of the uterine cervix. 1980. Am J Med 1980 ; 69 : 140-4.
PubMed
Kim do Y, et al. Small cell neuroendocrine carcinoma of the uterine cervix presenting with syndrome of inappropriate antidiuretic hormone secretion. Obstet Gynecol Sci 2013 ; 56 : 420-5.
PubMed
P.358 掲載の参考文献
日本産婦人科学会, 日本病理学会編. 漿液性腫瘍. 卵巣腫瘍取扱い規約 第1部 組織分類ならびにカラーアトラス. 第2版. 東京 : 金原出版 ; 2009. p.16-7.
 
Kurman RJ, et al. eds. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon : IARC ; 2014. p.17-24.
 
手島伸一, 石倉浩. 境界悪性漿液性腫瘍. 石倉浩, 手島伸一編. 卵巣腫瘍病理アトラス. 東京 : 文光堂 ; 2004. p.106-10.
 
安田政実. 漿液性腫瘍. 本山悌一, 坂本穆彦編. 腫瘍病理鑑別診断アトラス 卵巣腫瘍. 東京 : 文光堂 ; 2012. p.12-32.
 
Prat J, De Nictolis M. Serous borderline tumors of the ovary : a long-term follo-up study of 137 cases, including 18 with micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002 ; 26 : 1111-28.
 
May T, et al. Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of ovary. Gynecol Oncol 2010 ; 117 : 9-17.
PubMed
Seidman JD, et al. Surface epithelial tumors of the ovary. In : Kurman RJ, et al. eds. Blaustein's Pathology of the Female Genital Organs. 6th ed. New York : Springer Verlag ; 2011. p.679-784.
 
Brustman L, Seltzer V. Sister Joseph's nodule : seven cases of umbilical metastases from gynecologic malignancies. Gynecol Oncol 1984 ; 19 : 155-62.
 
P.364 掲載の参考文献
Argani P, et al. A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol 2010 ; 34 : 1395-406.
PubMed
Dickson MA, et al. Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition : clinical and molecular correlates. Int J Cancer 2013 ; 132 : 1711-7.
PubMed
Doyle LA, et al. PEComa of the gastrointestinal tract : clinicopathologic study of 35 cases with evaluation of prognostic parameters. Am J Surg Pathol 2013 ; 37 : 1769-82.
PubMed
Folpe AL, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin : a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 2005 ; 29 : 1558-75.
PubMed
Lee SE, et al. Ovarian perivascular epithelioid cell tumor not otherwise specified with transcription factor E3 gene rearrangement : a case report and review of the literature. Hum Pathol 2012 ; 43 : 1126-30.
 
Malinowska I, et al. Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas : further evidence for a biological distinction. Am J Surg Pathol 2012 ; 36 : 783-4.
PubMed
Rao Q, et al. Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas) : a clinicopathological study emphasizing extrarenal PEComas. Histopathology 2013 ; 62 : 642-50.
 
Russell CM, et al. Perivascular epithelioid cell tumor (PEComa) of the urinary bladder associated with Xp11 translocation. Ann Clin Lab Sci 2014 ; 44 : 91-8.
PubMed
Schoolmeester JK, et al. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract : clinicopathologic and immunohistochemical characterization of 16 cases. Am J Surg Pathol 2014 ; 38 : 176-88.
PubMed
Silva EG, et al. Uterine epithelioid leiomyosarcomas with clear cells : reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol 2004 ; 28 : 244-9.
PubMed
P.369 掲載の参考文献
Rutgers JL, Scully RE. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis. Cancer 1988 ; 61 : 546-54.
PubMed
Shappell HW, et al. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors : atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol 2002 ; 26 : 1529-41.
PubMed
Nagai Y, et al. Squamous predominance in mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type arising in endometriotic cysts. : a study of four cases. Am J Surg Pathol 2003 ; 27 : 242-7.
PubMed
浦野誠ほか. 卵巣ovarian mixed-epithelial papillary cystadenoma of borderline malignancy of mullerian type with squamous overgrowth (MEBMMSO) と考えられた2症例. 日婦病理会誌 2013 ; 4 : 101-4.
 
Kobel M, et al. Seromucinous tumours. In : Kurman RJ, et al. eds. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon : IARC ; 2014. p.38-40.
 

書評

最近チェックした商品履歴

Loading...